Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Assets (2016 - 2026)

Sanofi's Current Assets history spans 18 years, with the latest figure at $35.3 billion for Q1 2026.

  • On a quarterly basis, Current Assets fell 23.73% to $35.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $35.3 billion, a 23.73% decrease, with the full-year FY2025 number at $36.0 billion, down 20.83% from a year prior.
  • Current Assets hit $35.3 billion in Q1 2026 for Sanofi, down from $36.0 billion in the prior quarter.
  • Over the last five years, Current Assets for SNY hit a ceiling of $46.3 billion in Q1 2025 and a floor of $30.3 billion in Q2 2022.
  • Historically, Current Assets has averaged $37.1 billion across 5 years, with a median of $35.3 billion in 2026.
  • Biggest five-year swings in Current Assets: surged 1118.33% in 2022 and later dropped 23.73% in 2026.
  • Tracing SNY's Current Assets over 5 years: stood at $34.8 billion in 2022, then decreased by 5.18% to $33.0 billion in 2023, then surged by 37.91% to $45.5 billion in 2024, then decreased by 20.83% to $36.0 billion in 2025, then fell by 1.98% to $35.3 billion in 2026.
  • Business Quant data shows Current Assets for SNY at $35.3 billion in Q1 2026, $36.0 billion in Q4 2025, and $39.8 billion in Q3 2025.